Roche Sequencing Solutions, Inc.
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Previously recorded as Genia Technologies, Inc. (to 2020)
Previously recorded as Roche Nimblegen, Inc. (to 2017)
22
Ending by 2030
Jun 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 8 fees due Dec 4 to 27, 2026 · next Dec 4
- 8 fees due Jan 4 to 30, 2027 · next Jan 4
- 14 fees due Feb 6 to 28, 2027 · next Feb 6
- 9 fees due Mar 1 to 26, 2027 · next Mar 1
- 12 fees due Apr 1 to 30, 2027 · next Apr 1
- 5 fees due May 5 to 21, 2027 · next May 5
- 1 fee due Jun 19, 2027The maintenance fee for Two-way pump selectable valve and bypass waste channel (US 11,846,281) comes due Jun 19, 2027. Unpaid by Dec 20, 2027, it lapses early.
- 7 fees due Jul 2 to 30, 2027 · next Jul 2
- 3 fees due Aug 6 to 27, 2027 · next Aug 6
- 12 fees due Sep 3 to 26, 2027 · next Sep 3
- 7 fees due Oct 2 to 30, 2027 · next Oct 2
- 6 fees due Nov 5 to 14, 2027 · next Nov 5
Recent changes
- 7 of the patents on this record were granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,324,360 | High Throughput Nucleic Acid Sequencing by Expansion In force · High confidence | In force | High confidence | |
| US 8,349,565 | High throughput nucleic acid sequencing by expansion In force · From the USPTO record | In force | From the USPTO record | |
| US 9,920,386 | High Throughput Nucleic Acid Sequencing by Expansion In force · High confidence | In force | High confidence | |
| US 10,900,068 | Methods and systems for solution based sequence enrichment In force · From the USPTO record | In force | From the USPTO record | |
| US 7,939,259 | High Throughput Nucleic Acid Sequencing by Expansion In force · High confidence | In force | High confidence | |
| US 9,790,543 | Methods and systems for solution based sequence enrichment In force · From the USPTO record | In force | From the USPTO record | |
| US 8,461,854 | Systems and Methods for Characterizing a Molecule In force · High confidence | In force | High confidence | |
| US 9,377,437 | Systems and methods for characterizing a molecule In force · From the USPTO record | In force | From the USPTO record | |
| US 9,605,307 | Systems and Methods for Forming a Nanopore in a Lipid Bilayer In force · High confidence | In force | High confidence | |
| US 9,617,595 | Systems and methods for assembling a lipid bilayer on a substantially planar solid surface In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 366: 10 patents in force now held by others · 7 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
85 pending · 18 abandoned · 46 no status recorded